Lybrel

Low vitamin B6 status can promote accumulation of homocysteine, a sulfur‑containing amino acid that can damage the endothelium, increase oxidative stress, and promote clot formation, all of which are relevant to cardiovascular disease and stroke. Large observational studies and cross‑sectional analyses have shown that people with lower plasma pyridoxal‑5‑phosphate (active B6) levels have higher rates of stroke and other vascular events, and in some cohorts low B6 was a stronger predictor of stroke or transient ischemic attack than homocysteine itself. The encouraging finding from meta‑analyses and clinical trials is that B‑vitamin combinations including B6 can lower homocysteine and modestly reduce the combined risk of stroke, myocardial infarction, and vascular death in high‑risk patients, suggesting that maintaining adequate B6 is one useful piece of broader cardiovascular prevention

Low or depleted magnesium levels are associated with a higher likelihood of several cardiovascular problems, including arrhythmias, where people with low magnesium have been shown to have 2–4 times higher odds of these rhythm disturbances compared with those with normal levels. Low magnesium is also linked to worsening coronary artery disease, progression of heart failure, and development or aggravation of hypertension, driven by disrupted cardiac electrical stability, vascular function, and electrolyte balance. Even mild magnesium depletion may contribute to higher blood pressure over time, adding to the overall cardiovascular burden, especially in individuals with existing heart disease or multiple risk factors.

In the brain, vitamin B6 (pyridoxine) is needed to produce neurotransmitters and to keep homocysteine in check, so low B6 status has been linked to both depressed mood and subtle cognitive problems such as slower processing and poorer attention in some adults. Observational work in older populations suggests that lower blood levels or intakes of B6 tend to track with worse performance on memory, executive‑function, and psychomotor‑speed tests, raising concern that marginal B6 status may contribute to age‑related cognitive decline. Clinically, when B6 deficiency coexists with depression, correcting it is viewed as one modifiable factor that may help support clearer thinking and better cognitive function alongside standard psychiatric and lifestyle treatments.

Folate deficiency in the periconceptional period significantly increases the risk of neural tube defects (NTDs) such as spina bifida and anencephaly, because adequate folate is required for proper closure of the embryonic neural tube in the first month of pregnancy. Large observational datasets and randomized trials have shown that appropriate folic acid supplementation before conception and in early pregnancy can reduce NTD risk by roughly 50–70% in the general population, with even greater risk reduction in women with a prior NTD‑affected pregnancy. The practical implication is that all women of childbearing potential, not just those actively planning pregnancy, are typically advised to maintain adequate daily folic acid intake so that red‑cell folate stores are sufficient well before conception occurs.

Vitamin C deficiency weakens collagen in capillary and vascular walls, so severe scurvy can present with ocular hemorrhages in the conjunctiva and retina that threaten vision if not treated. Case reports and small series describe retinal hemorrhages, flame‑shaped hemorrhages, and even retrobulbar bleeding compressing the optic nerve, which can lead to optic neuropathy and visual loss in advanced cases. The encouraging point is that, when vitamin C deficiency is recognized early and promptly repleted, many ocular hemorrhages and visual symptoms can partially or fully resolve, making it critical to consider vitamin C status in patients with otherwise unexplained ocular bleeding and visual complaints.

Low or depleted magnesium levels place people with diabetes and metabolic syndrome (MetSyn) at higher risk of worsening glycemic control and insulin resistance because magnesium is essential for normal glucose metabolism and beta-cell function. When magnesium is low, these metabolic pathways become less efficient, amplifying blood sugar instability, lipid abnormalities, and other MetSyn features. Even moderate depletion can accelerate type 2 diabetes and MetSyn-related complications, underscoring the need for monitoring magnesium status in these vulnerable groups.